Applied Clinical Trials

Applied Clinical Trials-04-01-2022
Volume: 31
Issue: 4

Applied Clinical Trials-03-01-2022
Volume: 31
Issue: 3

Applied Clinical Trials-02-01-2022
Volume: 31
Issue: 1/2

Applied Clinical Trials-12-01-2021
Volume: 30
Issue: 12

Applied Clinical Trials-11-01-2021
Volume: 30
Issue: 11

Applied Clinical Trials-10-01-2021
Volume: 30
Issue: 10

Applied Clinical Trials-09-01-2021
Volume: 30
Issue: 9

Applied Clinical Trials-08-01-2021
Volume: 30
Issue: 7/8

Applied Clinical Trials-06-01-2021
Volume: 30
Issue: 6

Applied Clinical Trials-05-01-2021
Volume: 30
Issue: 5

Applied Clinical Trials-04-01-2021
Volume: 30
Issue: 4

Applied Clinical Trials-03-01-2021
Volume: 30
Issue: 3

Applied Clinical Trials-02-01-2021
Volume: 30
Issue: 1/2

Applied Clinical Trials-12-01-2020
Volume: 29
Issue: 12

Applied Clinical Trials-11-01-2020
Volume: 29
Issue: 11

Applied Clinical Trials-10-01-2020
Volume: 29
Issue: 10

Applied Clinical Trials-09-01-2020
Volume: 29
Issue: 9

Applied Clinical Trials-08-01-2020
Volume: 29
Issue: 7/8

Applied Clinical Trials-06-01-2020
Volume: 29
Issue: 6

Applied Clinical Trials-05-01-2020
Volume: 29
Issue: 5

Applied Clinical Trials-04-01-2020
Volume: 29
Issue: 4

Applied Clinical Trials-03-01-2020
Volume: 29
Issue: 3

Applied Clinical Trials-02-01-2020
Volume: 29
Issue: 2

Applied Clinical Trials-12-01-2019
Volume: 28
Issue: 12

Applied Clinical Trials-11-01-2019
Volume: 28
Issue: 11

Applied Clinical Trials-10-01-2019
Volume: 28
Issue: 10

Applied Clinical Trials-09-01-2019
Volume: 28
Issue: 9

Applied Clinical Trials-07-01-2019
Volume: 28
Issue: 7

Applied Clinical Trials-06-01-2019
Volume: 28
Issue: 6

Applied Clinical Trials-05-01-2019
Volume: 28
Issue: 5
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
IQVIA and Veeva Join Forces to Improve Efficiency and Patient Outcomes
2
Why Clinical Trials Are at a Crossroads and How Site Networks Are the Key to Success
3
Everything to Know About FDA’s Push Towards Radical Transparency in 2025
4
Phase IV Trial Shows Strong Immune Response from Moderna’s Updated Spikevax Against LP.8.1 Variant of COVID-19
5